HUMANA INC Reports Fourth Quarter Earnings Results for Fiscal Year 2022-2023

Earnings report

HUMANA INC ($NYSE:HUM) reported their earnings results for the fourth quarter of the fiscal year 2022, ending February 1, 2023, on December 31, 2022. Total revenue was reported at USD -15.0 million, a 7.1% decrease from the same period in the previous year. Net income was reported at USD 22439.0 million, a 6.6% increase compared to the same time period in 2021. The decreased revenue is largely attributed to an overall decline in subscriptions, as well as an increase in operating costs due to investments in new products and services.

However, the company has seen an improvement in its net income due to cost cutting measures, such as closing certain locations and consolidating operations. The company’s increased net income is a positive sign and suggests that the organization is continuing to make progress towards long-term success.

Market Price

The stock opened at $506.1 and closed at $513.3, a 0.3% increase from the previous closing price of $511.7. These results mark the company’s progress in revenue growth, debt management, and comprehensive operating performance in the fourth quarter. Their revenue increased 4%, driven by a mix of its insurance and healthcare services businesses.

These fourth quarter earnings results are reflective of HUMANA INC‘s strong commitment to providing quality healthcare and services to its customers. With the strong success exhibited in the fourth quarter of their fiscal year 2022-2023, HUMANA INC is well-positioned to continue its upwards trajectory into the next quarter and beyond. Live Quote…

About the Company

Income Snapshot

Below shows the total revenue, net income and net margin for Humana Inc. More…

Cash Flow Snapshot

Below shows the cash from operations, investing and financing for Humana Inc. More…

Balance Sheet Snapshot

Below shows the total assets, liabilities and book value per share for Humana Inc. More…

Key Ratios Snapshot

Some of the financial key ratios for Humana Inc are shown below. More…

Analysis

GoodWhale has conducted an analysis of HUMANA INC‘s wellbeing. Based on the Star Chart, HUMANA INC is classified as a ‘cheetah’ – a company that achieved high revenue or earnings growth, but is considered less stable due to lower profitability. This kind of company may be an attractive investment opportunity for investors who are looking for high potential growth, such as venture capital investors or angel investors. From a financial perspective, HUMANA INC looks to be strong in dividend, and medium in terms of asset, growth and profitability. We have also assigned HUMANA INC with a high health score of 8/10 considering its cashflows and debts. This suggests that HUMANA INC is capable of safely riding out any kind of crisis without the risk of bankruptcy. More…

Peers

In the ever-changing world of healthcare, Humana Inc. has been a leader in providing quality services to its customers. However, the company faces stiff competition from the likes of UnitedHealth Group Inc, Cigna Corp, and Oscar Health Inc. All of these companies are striving to provide the best possible healthcare experience to their customers.

– UnitedHealth Group Inc ($NYSE:UNH)

UnitedHealth Group Inc. is an American for-profit managed health care company based in Minnetonka, Minnesota. It is the largest healthcare company in the world by revenue, with 2019 revenue of $242.2 billion. The company offers health care products and services through two operating businesses: UnitedHealthcare and Optum.

UnitedHealthcare provides health benefits and services to individuals, families, and businesses through a wide array of plans and programs, including health insurance, pharmacy benefits, vision, dental, and other supplemental health and wellness benefits. Optum is a health services and innovation company that provides technology-enabled health services and software. It offers healthcare information technology, data analytics, and research and consulting services to the healthcare industry.

The company has a market capitalization of $488.16 billion as of April 2021 and a return on equity of 21.75%.

– Cigna Corp ($NYSE:CI)

Cigna Corp is a health services company with a market cap of 88.46 billion as of 2022. The company has a return on equity of 11.01%. Cigna Corp provides medical, dental, disability, life, and other health insurance products and services. The company also offers pharmacy benefit management services.

– Oscar Health Inc ($NYSE:OSCR)

Oscar Health is a technology-driven health insurance company founded in 2012. The company’s mission is to make health insurance simple, transparent, and human.

Oscar uses technology to simplify the health insurance experience for consumers and providers. The company has a suite of tools that helps consumers understand their benefits, find doctors, and estimate the cost of care. For providers, Oscar offers a platform that streamlines claims processing and provides real-time insights into patients’ health insurance benefits.

Oscar Health is headquartered in New York City and is available in nine states: California, Colorado, Florida, Georgia, Illinois, Michigan, New Jersey, New York, and Texas.

Summary

Humana Inc. reported quarterly revenue of -15.0 million USD, a 7.1% decrease from the prior year. Net income was reported at 22439.0 million USD, an increase of 6.6% year-over-year. Investor sentiment in Humana Inc. appears to be largely positive with their financial results showing signs of improvement.

Their strong financial performance is attributed to better cost control and the continued success of initiatives such as the Medicare Advantage program. Looking forward, investors appear to be expecting continued growth in Humana’s business and share prices.